The role of selected mediators of inflammation in the pathogenesis of cancer

REVIEW ARTICLE

The role of selected mediators of inflammation in the pathogenesis of cancer

Zofia Marchewka 1 , Monika Gielniak 1 , Agnieszka Piwowar 1

1. Katedra i Zakład Toksykologii Uniwersytetu Medycznego im. Piastów Śląskich we Wrocławiu Pracownia Markerów Nefrotoksyczności Środowiskowej,

Published: 2018-03-20
DOI: 10.5604/01.3001.0011.6675
GICID: 01.3001.0011.6675
Available language versions: en pl
Issue: Postepy Hig Med Dosw 2018; 72 : 175-183

 

Abstract

The role of the immune system, consisting of many different types of cells and proteins, is to recognize and/or reaction to “foreign material”. Disorders of the immune system, among others may lead to inflammatory diseases and cancers. The cytokines, such as IL-1, -2, -4, -6, -8, -10, -13, -15, -17 i IL-18, play an important, and often divergence role in the cancer progression. They can exhibit a different activity, often opposite, depending on their source as well as its activity in environmental. The article focuses in particular on three interleukins: IL-6, IL-8 and IL-18, discussing in detail their contribution to the pathogenesis of cancer. Current views on the role of these interleukins in the cancer pathogenesis in different aspects of this process are presented. Both their pro- and anti-tumor activity, their role in the proliferation, migration, growth and differentiation of cancer cells as well as in the promotion of tumor metastases to organs was described. We discussed their impact on the regulation of angiogenesis, the most important stage of tumor progression, and their role in the weakening of the process of apoptotic cell death. Presented data can be used to create practical guidelines in the cancer fighting (prevention and treatment) by modulating the activity of these cytokines.

Full text

Skip to content